JamesHRevkinMDFACC, FACP, FCCP

PubMed

• Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design.
  John D Groarke, Susie M Collins, Shannon L Lubaczewski, Danna M Breen, Magdalena A Harrington, Ira Jacobs, Ruolun Qiu, Michelle I Rossulek, Aditi R Saxena, Jeffrey Cra...> ;Journal of Cachexia, Sarcopenia and Muscle. 2024 Mar 18
• A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia.
  Jeffrey Crawford, Roberto A Calle, Susie M Collins, Yan Weng, Shannon L Lubaczewski, Clare Buckeridge, Ellen Q Wang, Magdalena A Harrington, Anil Tarachandani, Michell...> ;Clinical Cancer Research. 2024 Feb 1
• 3 citations
  ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening ...
  Daniel E Singer, Steven J Atlas, Alan S Go, Renato D Lopes, Steven A Lubitz, David D McManus, James H Revkin, Donna Mills, Lori A Crosson, Judith C Lenane, Ronald S Ar...> ;American Heart Journal. 2022 Jul 1
• 31 citations
  Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week
  Harriette G.C. Van Spall, Anuradha Lala, Thomas F. Deering, Barbara Casadei, Faiez Zannad, Padma Kaul, Roxana Mehran, Gail D. Pearson, Monica R. Shah, Martha Gulati, C...> ;Journal of the American College of Cardiology. 2021 Jun 15
• Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank.
  Jonathan H. Seltzer, Ann T. Farrell, Neil A. Goldenberg, Christoph P. Hornik, Daniel Keene, Mitchell W. Krucoff, Concetta Lipardi, Patricia Massicotte, Dirk Mentzer, P...> ;American Heart Journal. 2020 Feb 28
• 38 citations
  Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab.
  Paul M. Ridker, Lynda M. Rose, John J.P. Kastelein, Raul D. Santos, Caimiao Wei, James H. Revkin, Carla Yunis, Jean-Claude Tardif, Charles L. Shear> ;Journal of Clinical Lipidology. 2018 Jul 1
• 250 citations
  Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
  Paul M. Ridker, Jean-Claude Tardif, Pierre Amarenco, William T. Duggan, Robert J. Glynn, J. Wouter Jukema, John J.P. Kastelein, Albert M. Kim, Wolfgang Koenig, Steven ...> ;The New England Journal of Medicine. 2017 Mar 17
• 429 citations
  Cardiovascular efficacy and safety of bococizumab in high-risk patients
  Paul M. Ridker, James H. Revkin, Pierre Amarenco, Robert Brunell, Madelyn Curto, Fernando Civeira, Marcus Flather, Robert J. Glynn, Jean Gregoire, J. Wouter Jukema, Yu...> ;The New England Journal of Medicine. 2017 Apr 20
• 41 citations
  Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Ratio...
  Paul M. Ridker, Pierre Amarenco, Robert Brunell, Robert J. Glynn, J. Wouter Jukema, John J.P. Kastelein, Wolfgang Koenig, Steven E. Nissen, James H. Revkin, Raul D. Sa...> ;American Heart Journal. 2016 Aug 1
• 1 citations
  Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [...
  Stefan D. Anker, Stefan Schroeder, Dan Atar, Jeroen J. Bax, Claudio Ceconi, Martin R. Cowie, Adam Crisp, Fabienne Dominjon, Ian Ford, Hossein Ardeschir Ghofrani, Savio...> ;European Journal of Heart Failure. 2016 Jun 1
• 62 citations
  Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
  Stefan D. Anker, Stefan Schroeder, Dan Atar, Jeroen J. Bax, Claudio Ceconi, Martin R. Cowie, Adam Crisp, Fabienne Dominjon, Ian Ford, Hossein Ardeschir Ghofrani, Savio...> ;European Journal of Heart Failure. 2016 May 1
• 14 citations
  Rate of change in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view
  Michiel L. Bots, Allen J. Taylor, John J.P. Kastelein, Sanne A.E. Peters, Hester M. den Ruijter, Charles H. Tegeler, Damiano Baldassarre, James H. Stein, Daniel H. O'L...> ;Journal of Hypertension. 2012 Sep 1
• 12 citations
  Surrogate endpoints in randomized cardiovascular clinical trials.
  Michael J. Domanski, Stuart J. Pocock, Corine Bernaud, Jeffrey S. Borer, Nancy L. Geller, James H. Revkin, Faiez Zannad> ;Fundamental & Clinical Pharmacology. 2011 Aug 1
• 2277 citations
  Effects of Torcetrapib in Patients at High Risk for Coronary Events
  Philip J. Barter, Mark J. Caulfield, Mats Eriksson, Scott M. Grundy, John J.P. Kastelein, Michel Komajda, Jose Lopez-Sendon, Lori Mosca, Jean-Claude Tardif, David D. W...> ;The New England Journal of Medicine. 2007 Nov 22
• 354 citations
  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.
  Michiel L. Bots, Frank L.J. Visseren, Gregory W. Evans, Ward A. Riley, James H. Revkin, Charles H. Tegeler, Charles L. Shear, William T. Duggan, Ralph M Vicari, Dieder...> ;Lancet. 2007 Jul 14
• 728 citations
  Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
  Steven E. Nissen, Jean-Claude Tardif, Stephen J. Nicholls, James H. Revkin, Charles L. Shear, William T. Duggan, Witold Rużyłło, William Bachinsky, Gregory P. Lasala, ...> ;The New England Journal of Medicine. 2007 Mar 29
• 498 citations
  Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia
  John J.P. Kastelein, Sander I. van Leuven, Leslie Burgess, Greg Evans, Jan Albert Kuivenhoven, Philip J. Barter, James H. Revkin, Diederick E. Grobbee, Ward A. Riley, ...> ;The New England Journal of Medicine. 2007 Apr 19
• 31 citations
  Designs of RADIANCE 1 and 2:carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis
  John J.P. Kastelein, Sander I. van Leuven, Gregory W. Evans, Ward A. Riley, James H. Revkin, Charles L. Shear, Michiel L. Bots> ;Current Medical Research and Opinion. 2007 Mar 16
• 53 citations
  Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future
  James H. Revkin, Charles L. Shear, Hubert G. Pouleur, Steven W. Ryder, David G. Orloff> ;Pharmacological Reviews. 2007 Mar 1
• 116 citations
  Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels...
  James M. McKenney, Michael H. Davidson, Charles L. Shear, James H. Revkin> ;Journal of the American College of Cardiology. 2006 Nov 7
• 100 citations
  Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels
  Michael H. Davidson, James M. McKenney, Charles L. Shear, James H. Revkin> ;Journal of the American College of Cardiology. 2006 Nov 7
• 19 citations
  Cardiac endothelial transport and metabolism of adenosine and inosine
  Lisa M. Schwartz, Thomas R. Bukowski, James H. Revkin, James B. Bassingthwaighte> ;The American Journal of Physiology. 1999 Sep 1
• 3 citations
  A collaborative project in Connecticut to improve the care of patients with acute myocardial infarction.
  Thomas P. Meehan, Martha J. Radford, Vaccarino Lv, Louis D. Gottlieb, McGovern-Hughes B, Herman Mv, James H. Revkin, Michael L. Therrien, Marcia K. Petrillo, Harlan M....> ;Connecticut Medicine. 1997 Mar 1
• 12 citations
  A Collaborative Project in Connecticut to Improve the Care of Patients with Acute Myocardial Infarction
  Thomas P. Meehan, Martha J. Radford, L. Viola Vaccarino, Louis D. Gottlieb, Barbara McGovern-Hughes, Michael V. Herman, James H. Revkin, Michael L. Therrien, Marcia K....> ;The Joint Commission Journal on Quality Improvement. 1996 Nov 1
• 23 citations
  Optimal timing and indications for cholecystectomy in cardiac transplant patients.
  Dennis G. Begos, Kenneth L. Franco, John C. Baldwin, Forrester A. Lee, James H. Revkin, Irvin M. Modlin> ;World Journal of Surgery. 1995 Jul 1
• Join now to see all